+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Narcolepsy Drugs Market by Drug Class, Distribution Channel, Formulation, End User - Global Forecast to 2030- Product Image
Narcolepsy Drugs Market by Drug Class, Distribution Channel, Formulation, End User - Global Forecast to 2030- Product Image
Sale

Narcolepsy Drugs Market by Drug Class, Distribution Channel, Formulation, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674140
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The narcolepsy drugs market is evolving rapidly, driven by advances in diagnostics, a broadened focus on patient needs, and innovation in both drug formulations and digital health tools. Emerging therapies, changing regulatory landscapes, and new delivery models are shaping growth and offering fresh opportunities for industry leadership.

Market Snapshot: Narcolepsy Drugs Market Overview

The Narcolepsy Drugs Market grew from USD 3.28 billion in 2024 to USD 3.51 billion in 2025 and is projected to reach USD 4.83 billion by 2030, expanding at a CAGR of 6.64%. This sustained growth is a direct result of clinical innovation, greater disease awareness, and dynamic changes in distribution and patient engagement models. The current market climate emphasizes both differentiated therapeutics and solutions that enhance patient outcomes through integrated care pathways.

Scope & Segmentation

  • Drug Class: Amphetamine Salts, Modafinil Derivatives (Armodafinil, Modafinil), Novel Agents (Pitolisant, Solriamfetol), Sodium Oxybate
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Formulation: Capsules, Solution, Tablets
  • End User: Home Use, Hospitals, Sleep Clinics
  • Region: Americas (including United States and key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (spanning United Kingdom, Germany, France, other major countries), Asia-Pacific (highlighting China, India, Japan, Australia, additional markets)
  • Companies Profiled: Jazz Pharmaceuticals plc, Harmony Biosciences Holdings, Inc., Avadel Pharmaceuticals plc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Hikma Pharmaceuticals PLC, Sandoz Inc., Lupin Limited, Cipla Limited, Glenmark Pharmaceuticals Ltd.

Key Takeaways for Decision Makers

  • Market growth is underpinned by a shift toward mechanism-driven drug development and refined personalized therapies addressing diverse symptom profiles beyond wakefulness.
  • Digital health integration, such as wearable patient monitors and telehealth support, is enhancing adherence and fine-tuning of treatment regimens, resulting in more responsive care models.
  • Distribution models are rapidly diversifying. Online pharmacies and hybrid retail solutions offer seamless patient experiences, while hospital pharmacies retain a critical role in therapy initiation and management of complex cases.
  • Home-based administration is gaining preference, supported by remote consultations and collaborative digital platforms that integrate pharmacotherapy and behavioral interventions.
  • Strategic partnerships between manufacturers, regional distributors, and digital health platforms are key to supporting agile responses to regulatory, economic, and tariff shifts.
  • Regional heterogeneity in regulation, healthcare infrastructure, and reimbursement means that customized market entry and commercialization strategies are increasingly essential for sustained success.

Impact of US Tariff Adjustments on the Narcolepsy Drugs Market

Upcoming tariff changes in the United States are set to influence raw material sourcing and supply chain costs for narcolepsy drugs. Higher duties on imported active pharmaceutical ingredients could prompt a shift toward domestic or alternative global suppliers, resulting in increased logistical complexity. This may place margin pressures on hospital and retail pharmacies and challenge online channels to maintain competitive pricing. Proactive risk management including flexible sourcing, strategic logistics partnerships, and potential risk-sharing agreements with payers will be critical to maintaining stable patient access and adherence in this landscape.

Methodology & Data Sources

This research utilizes a robust mixed-methods approach, combining in-depth interviews with leading clinicians and industry experts with comprehensive secondary analysis from peer-reviewed literature, regulatory documents, and proprietary databases. Primary interview insights were cross-validated with global clinical trial and market data. Scenario modeling and supply chain risk assessments further underpin the reliability of findings, ensuring rigorous and transparent intelligence for stakeholders.

Why This Report Matters

  • Enables senior leaders to benchmark evolving therapeutic paradigms, distribution models, and digital integration trends in narcolepsy care.
  • Equips stakeholders with actionable insights for forecasting, risk modeling, and strategic resource allocation amid shifting regulatory and tariff frameworks.

By leveraging these trustworthy insights, organizations can efficiently align innovation, supply chain decisions, and patient engagement strategies to meet emerging market needs.

Conclusion

The narcolepsy drugs market is in a phase of significant transformation and sustained growth. Strategic alignment across product development, distribution, and digital health is essential. Tailored tactics and collaborative partnerships position stakeholders to drive robust patient outcomes and capture evolving opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Narcolepsy Drugs Market, by Drug Class
8.1. Introduction
8.2. Amphetamine Salts
8.3. Modafinil Derivatives
8.3.1. Armodafinil
8.3.2. Modafinil
8.4. Novel Agents
8.4.1. Pitolisant
8.4.2. Solriamfetol
8.5. Sodium Oxybate
9. Narcolepsy Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Narcolepsy Drugs Market, by Formulation
10.1. Introduction
10.2. Capsules
10.3. Solution
10.4. Tablets
11. Narcolepsy Drugs Market, by End User
11.1. Introduction
11.2. Home Use
11.3. Hospitals
11.4. Sleep Clinics
12. Americas Narcolepsy Drugs Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Narcolepsy Drugs Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Narcolepsy Drugs Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Jazz Pharmaceuticals plc
15.3.2. Harmony Biosciences Holdings, Inc.
15.3.3. Avadel Pharmaceuticals plc
15.3.4. Teva Pharmaceutical Industries Ltd.
15.3.5. Viatris Inc.
15.3.6. Hikma Pharmaceuticals PLC
15.3.7. Sandoz Inc.
15.3.8. Lupin Limited
15.3.9. Cipla Limited
15.3.10. Glenmark Pharmaceuticals Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NARCOLEPSY DRUGS MARKET MULTI-CURRENCY
FIGURE 2. NARCOLEPSY DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. NARCOLEPSY DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NARCOLEPSY DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY AMPHETAMINE SALTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY ARMODAFINIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY PITOLISANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SOLRIAMFETOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SODIUM OXYBATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOME USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NARCOLEPSY DRUGS MARKET SIZE, BY SLEEP CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NARCOLEPSY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 44. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 45. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 46. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 48. CANADA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 50. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 51. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 54. MEXICO NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 81. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 82. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 83. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 85. GERMANY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 88. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 89. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 100. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 101. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 105. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 106. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 107. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 109. SPAIN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 129. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 130. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 133. DENMARK NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 142. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 143. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. QATAR NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 148. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 151. FINLAND NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 166. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 167. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. EGYPT NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 172. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 173. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 175. TURKEY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 184. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 185. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. NORWAY NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 190. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 191. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. POLAND NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC NARCOLEPSY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 207. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 208. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 209. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 210. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. CHINA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 214. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 215. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 216. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. INDIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 221. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 222. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 224. JAPAN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 244. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 245. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 246. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. THAILAND NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY MODAFINIL DERIVATIVES, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY NOVEL AGENTS, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN NARCOLEPSY DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. NARCOLEPSY DRUGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 280. NARCOLEPSY DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Narcolepsy Drugs market report include:
  • Jazz Pharmaceuticals plc
  • Harmony Biosciences Holdings, Inc.
  • Avadel Pharmaceuticals plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sandoz Inc.
  • Lupin Limited
  • Cipla Limited
  • Glenmark Pharmaceuticals Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.83 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Narcolepsy Treatment Market by Drug Class, Disorder Type, Age Group, Distribution Channel - Global Forecast to 2030 - Product Image

Narcolepsy Treatment Market by Drug Class, Disorder Type, Age Group, Distribution Channel - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Narcolepsy Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Narcolepsy Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report and Forecast 2024-2032 - Product Image

Narcolepsy Drugs Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033 - Product Image

Narcolepsy Drugs Market Report by Type, Disease Type, Therapeutic Type, and Region 2025-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.